Neurodegenerative diseases, such as Alzheimer's and Parkinson's, both involve an accumulation of protein aggregates [1],[2]. Monitoring and studying small oligomers, which are present in the early stages of disease, can be challenging, due to their transient and heterogeneous nature [1].